Mary DiBiase Email & Phone

Chief Operating Officer @ X4 Pharmaceuticals

SVP Technical Operations and Quality @ X4 Pharmaceuticals

VP Technical Operations and Program Management @ EPIRUS Biopharmaceuticals

VP Product Operations Specialty Care and Biotechnology Operating Unit @ Pfizer

Senior Director CMC Management Technical Development @ Biogen Idec

Associate Director Formulation and Drug Product Development @ Biogen Idec

Associate Scientific Director, Senior Research Scientist @ Alkermes

- @ Bentley University - McCallum Graduate School of Business

- @ University of Rhode Island

- @ University of London

Strategic Planning, Program Management, Product Development, Global Alliance Management, Asset Life Cycle Management, Matrix Management, Due Diligence, Staff Development, Long Range Planning, Biologics, Small Molecules, Product Manufacturing, Formulation, Regulatory Strategy Development, Drug Delivery, Contract Manufacturing, Cross-functional Team Leadership, Drug Development, Assay Development, Biopharmaceuticals, Biotechnology, Clinical Trials, Commercialization, Drug Discovery, GMP, IND, Monoclonal Antibodies, Pharmaceutics, Strategy, Development, Regulatory Strategy, Microsoft Excel, Cross Functional Team Leadership, Asset Life Cycle, Customer Service, Operations, Drug Product, Global Alliance, Leadership, Cross Functional Team, Pharmaceutical Industry

Mary DiBiase, based in Cambridge, MA, US, is currently a Chief Operating Officer at X4 Pharmaceuticals. Mary DiBiase brings experience from previous roles at X4 Pharmaceuticals, EPIRUS Biopharmaceuticals, Pfizer, Biogen Idec, Biogen Idec, Alkermes. Mary DiBiase holds various educational qualifications from Bentley University - McCallum Graduate School of Business. With a robust skill set that includes Strategic Planning, Program Management, Product Development, Global Alliance Management, Asset Life Cycle Management, Mary DiBiase demonstrates proficiency in a wide range of areas.